Molecular diagnostic testing in exanthema — the PCR, multiplex PCR, and next-generation sequencing platforms enabling rapid, specific identification of viral, bacterial, and drug-induced rash etiologies representing the fastest-advancing diagnostic segment — creates the most accuracy-focused market opportunity, with the Exanthema Market reflecting molecular diagnostics as the...